Bursitis

Bursitis: A Nutrition and Natural Health Reference

1. Definition and Overview

Bursitis is the acute or chronic inflammation of a bursa — a fluid-filled sac lined by a synovial membrane that functions to reduce friction between tendons and either bone or skin. There are over 150 known bursae in the human body, and their function is to facilitate movement in the musculoskeletal system, creating a cushion between tissues that move against one another.

There are two types of bursae: constant and adventitial. Both types can be involved in acute or chronic bursitis. Adventitial bursae form later in life in response to repeated trauma or constant friction and pressure.

2. Clinical Presentation

Bursitis is typically associated with redness and swelling, but may also be associated with pain, warmth, or decreased range of motion. When bursitis occurs, the bursa enlarges with fluid, and any movement against or direct pressure upon the bursa will precipitate pain for the patient.

Triggers such as overuse or trauma result in irritation that causes an increase in synovial fluid and enlargement of the bursae. Once enlarged, the inflamed bursae push on surrounding tissue — including bone, muscle, ligaments, and skin — and cause symptoms such as redness, swelling, pain, or decreased range of motion.

If an acute case of bursitis fails to resolve, it can progress to chronic bursitis. Chronically, affected bursae show expansion and increased intrabursal pressure. Patients tend to exhibit increased swelling and thickening of the bursal sac out of proportion to pain.

3. Commonly Affected Sites

While there are more than 150 bursae in the human body, common sites of bursitis include the shoulder, elbow, hip, and knee. The three upper-extremity bursae that are most commonly affected by bursitis are the subacromial, subscapular, and olecranon bursae.

4. Body Systems Involved

Bursitis primarily engages the musculoskeletal system — specifically the connective tissues of the bursa, the surrounding tendons, ligaments, and periarticular muscles — but the inflammatory process draws in the immune system as well. Histological and immunological perturbations in bursitis include alterations of tissue morphology, infiltration of macrophages and some T cells, and enhanced expression of proinflammatory cytokines, such as interleukin (IL)-6, IL-1β, and tumor necrosis factor alpha (TNF-α).

Substantial overlap of enhanced expression of IL-6, IL-1β, TNF-α, and infiltrating macrophages has been found in bursitis irrespective of the underlying cause. This confirms that regardless of whether the trigger is mechanical, infectious, or autoimmune, the final common pathway is a shared proinflammatory cytokine cascade within the synovium-lined bursal tissue.

If bursitis does not resolve, it may lead to irritation and inflammation of surrounding tissues — including tendons, muscles, ligaments, and skin — which may increase pain, swelling, and deterioration of tissues.

5. Contributing and Associated Factors

5.1 Mechanical and Occupational Factors

Irritation of the bursa, often by repetitive movements or stresses, can lead to microtrauma of the bursa, inducing inflammation. Risk factors include repetitive physical activity and sedentary behaviour that prolongs stress on load-bearing bursae. The highest incidence of bursitis occurs in runners, followed by occupations that involve heavy workload or frequent kneeling.

5.2 Systemic and Rheumatologic Conditions

Acute trauma, infection, or autoimmune dysfunction — such as rheumatoid arthritis, systemic lupus erythematosus, and gout — can also cause bursitis. Uric acid crystal deposition associated with gouty arthritis can lead to bursitis, and is sometimes accompanied by kidney stones.

5.3 Metabolic and Comorbidity Factors

Obesity, smoking, fibromyalgia, hypothyroidism, alcoholism, diabetes mellitus, arthritis, and emotional stress correlate with slower and reduced healing and recovery from bursitis.

A large retrospective cohort study (2005–2020) involving 10,301 patients with olecranon bursitis and 44,608 controls examined the metabolic risk profile of bursitis in depth. Olecranon bursitis was significantly associated with male gender (OR: 1.406), hyperlipidemia (OR: 1.239), statin use (OR: 1.117), and smoking (OR: 1.068). Age and BMI were significant continuous variables influencing bursitis risk, particularly in older patients and those with elevated BMI. Male gender, hyperlipidemia, and smoking were identified as key risk factors for olecranon bursitis, with hyperlipidemia posing a notable risk in older individuals and those with higher BMI. Statin use did not significantly alter risk in hyperlipidemic patients. Further studies are needed to clarify the mechanisms behind these associations.

5.4 Immunocompromised States and Septic Bursitis

Septic bursitis results from an infection of the bursal sac, often secondary to traumatic injury to overlying skin, dermatologic skin lesions such as psoriasis, eczema, or dermatitis, or seeding from nearby cellulitis. For septic bursitis, immunocompromised patients — such as people with diabetes, those with certain rheumatologic disorders, people who suffer from alcoholism, or those with HIV — are at increased risk.

5.5 Anatomical and Biomechanical Factors

Musculoskeletal imbalances or certain anatomic variants are sometimes associated with the development of bursitis. Decreased core strength and chronic back pain can exacerbate trochanteric bursitis, which itself is often precipitated by gluteus minimus or medius tendinopathy, while mechanical factors such as pes planus and genu valgum are risk factors for the development of pes anserine bursitis.

5.6 Age

While bursitis affects people of all ages, the elderly may be at greater risk, given that many older people are afflicted by osteoarthritis and other chronic diseases, which can increase the risk of bursitis.

6. Nutrients Studied or Traditionally Used in Relation to Bursitis

No nutrients have been studied in clinical trials exclusively targeting bursitis. Evidence below is drawn either from the broader context of musculoskeletal and synovial inflammation or from conditions (such as gouty bursitis and rheumatoid arthritis) that are directly associated with bursitis. Traditional uses are separated clearly from scientific evidence.

6.1 Omega-3 Polyunsaturated Fatty Acids (EPA and DHA)

Traditional use: Cod liver oil and fish oils have been used in northern European and coastal traditional diets for generations to ease joint stiffness and pain, with their use for "rheumatic" complaints predating modern pharmacology.

Scientific evidence: Dietary omega-3 fatty acids have a variety of anti-inflammatory and immune-modulating effects. The long-chain polyunsaturates derived from marine oils — eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) — are the most potent in this respect. The omega-3 PUFAs EPA and DHA have been shown to reduce inflammation, with some studies showing clinical improvements in rheumatoid arthritis.

A 2025 systematic review and meta-analysis pooling 41 randomized controlled trials encompassing 3,759 participants — spanning migraine, RA, neuropathic pain, and musculoskeletal conditions — found that omega-3 supplementation reduced chronic pain. This finding is consistent with previous reviews suggesting that prolonged supplementation is necessary to achieve clinically meaningful analgesic effects. PUFAs could prevent and treat age-related musculoskeletal diseases, including osteoarthritis, by reducing oxidative stress and inflammation and controlling the growth, differentiation, apoptosis, and autophagy of cells.

Evidence strength: Moderate-to-strong for general musculoskeletal inflammatory pain and rheumatoid arthritis; no trials specifically in bursitis populations.

6.2 Vitamin C (Ascorbic Acid)

Traditional use: Citrus fruits and other vitamin C-rich foods have long been recommended in folk traditions for wound healing, joint pain, and inflammatory complaints. Vitamin C was also identified historically in the prevention and treatment of scurvy, a condition featuring joint and connective tissue pathology.

Scientific evidence: Vitamin C has an essential role in connective tissue healing, being a cofactor for prolyl hydroxylase and lysyl hydroxylase, enzymes that catalyze the hydroxylation of proline and lysine residues of procollagen, promoting the proper folding of the stable collagen triple-helix conformation. Investigations on the biochemical pathways after a musculoskeletal injury have suggested that vitamin C may be a viable supplement to enhance collagen synthesis and soft tissue healing.

A systematic review of 18 studies on vitamin C and tissue healing found that overall, vitamin C supplementation improved healing outcomes in certain pathologies, predominantly pressure ulcers. However, many of the studies had small sample sizes, combined nutritional treatments, and did not test baseline vitamin C.

Regarding gout-associated bursitis specifically: Vitamin C decreases uric acid levels and can help prevent gout attacks. Most studies suggest getting at least 500 mg per day.

Evidence strength: Mechanistic evidence is well established for collagen synthesis and soft tissue repair; clinical trial evidence in musculoskeletal conditions is preliminary. Evidence for uric acid reduction is moderate. No bursitis-specific trials exist.

6.3 Vitamin D

Traditional use: Historically, sun exposure and cod liver oil (both sources of vitamin D) were used empirically for "rheumatic" and bone-related complaints in traditional European medicine.

Scientific evidence: Vitamin D status influences musculoskeletal health. Low vitamin D levels may lead to clinical manifestations including bone pain, muscle weakness, falls, low bone mass, and fractures, with subsequent diagnoses of osteomalacia, osteoporosis, and myopathy. Research in related synovial joint conditions has explored vitamin D's role in inflammation modulation. Studies cited in a 2024 systematic review examined the effect of vitamin D supplementation on synovial tissue volume and subchondral bone marrow lesion volume in symptomatic knee osteoarthritis.

Evidence strength: Established for bone and musculoskeletal function generally; associations with synovial inflammation are demonstrated in animal and observational studies. Intervention evidence specifically in bursitis is absent.

6.4 Magnesium

Traditional use: Magnesium-rich foods (nuts, seeds, dark leafy greens) and Epsom salt (magnesium sulfate) baths have a long folk tradition of use for muscle and joint pain relief.

Scientific evidence: Magnesium has been shown to enhance the adhesion of synovial mesenchymal stem cells and promote cartilaginous matrix assembly. In animal models, injecting a magnesium ion solution directly into the osteoarthritic joint can relieve pain and slow down cartilage lesions. Magnesium ions also promote the formation of chondrocytes from synovial mesenchymal stem cells. Research on synovial tissue in arthritis has shown that levels of TNF-α, IL-6, IL-8, and NF-κB activity are increased in rheumatoid arthritis and have been associated with joint inflammation and implicated in synovial hyperplasia and joint damage.

Evidence strength: Preclinical (animal and cell-culture) data are suggestive; direct human clinical trial evidence for magnesium in bursitis or synovial bursal inflammation is lacking. Evidence for joint health is largely from osteoarthritis models.

7. Herbs and Natural Ingredients Studied or Traditionally Used

7.1 Turmeric / Curcumin (Curcuma longa)

Traditional use: Medicinal properties of turmeric (Curcuma longa L.), a plant used for centuries as an anti-inflammatory, are attributed to its polyphenolic curcuminoids, where curcumin predominates. Traditional medicine systems such as Ayurveda have used turmeric for centuries to treat various inflammatory conditions, but the translation of these traditional uses to bursitis is mainly extrapolative.

Scientific evidence: Curcumin is a potent anti-inflammatory that blocks inflammatory cytokines and enzymes, including 5-LOX and cyclooxygenase-2 (COX-2), the target of the drug celecoxib. A systematic review and meta-analysis of randomized controlled trials on curcumin in arthritis (PMC, 2022) found that half of included citations focused on obesity-associated metabolic disorders or musculoskeletal disorders where inflammation is a key driver, and beneficial effects on clinical outcomes and/or biomarkers were reported for most citations (75%) in studies that were primarily double-blind, randomized, and placebo-controlled trials.

In 2016, an industry-sponsored systematic review of randomized controlled trials found that 1,000 mg per day of curcumin reduced osteoarthritis pain and inflammation as well as NSAIDs like diclofenac and ibuprofen. A meta-analysis published in Frontiers in Immunology (2023) reported that curcumin supplementation was effective in reducing clinical symptoms in rheumatic diseases, and use in rheumatoid arthritis patients could reduce the possibility of unpleasant consequences.

However, there are no large, high-quality clinical trials specifically investigating curcumin supplementation in patients with bursitis. In both in vitro and in vivo preclinical studies, curcumin has shown promise in ameliorating inflammation associated with chronic disease; questions remain as to whether these benefits fully extend to humans.

Evidence strength: Moderate evidence for general musculoskeletal inflammatory conditions and osteoarthritis; evidence in bursitis specifically is absent. A significant limitation is poor bioavailability of standard curcumin formulations.

7.2 Boswellia (Boswellia serrata)

Traditional use: Boswellia resin (frankincense) has been used in Ayurvedic medicine for centuries under the name Shallaki, primarily as a remedy for inflammatory joint disease and pain. It was prepared as a resin extract consumed orally or applied topically.

Scientific evidence: Boswellia serrata is considered a potent anti-inflammatory, anti-arthritic, and analgesic agent that may serve as a treatment option for osteoarthritis. A meta-analysis of seven randomized controlled trials involving 545 patients found that compared with the control group, Boswellia and its extract significantly relieved pain as measured by VAS (WMD −8.33; 95% CI −11.19, −5.46; p<0.00001).

A pilot study of a Boswellia serrata and bromelain supplement in osteoarthritis patients reported that at follow-up (3.0 ± 0.7 months), a significant improvement was observed for 7 of 10 quality-of-life questions and, overall, for the total quality-of-life score. The most significant improvements were observed in the joints that were more strongly affected at baseline.

Evidence strength: Moderate for osteoarthritis joint pain. No bursitis-specific RCTs. The boswellic acids in Boswellia are thought to inhibit 5-lipoxygenase, a key enzyme in the leukotriene inflammatory pathway.

7.3 Devil's Claw (Harpagophytum procumbens)

Traditional use: Devil's Claw is an extract obtained from the root of the Harpagophytum procumbens plant, a member of the sesame family found in the Kalahari region in South Africa. Indigenous peoples of southern Africa traditionally used the tubers of this plant to treat fever, pain, and digestive disorders. The herbal plants have been utilized for indigestion, blood diseases, fevers, sprains, and rheumatic conditions. The plant has been promoted as a food supplement for degenerative arthritis conditions.

Scientific evidence: Devil's Claw, turmeric, and bromelain are nutraceuticals that have demonstrated anti-inflammatory and analgesic properties and may be potential solutions in the treatment of acute or chronic joint pain. Their analgesic effect, however, is generally considered mild to moderate, and the relevance of their clinical use remains subject to discussion.

A multicenter observational study evaluated a complex of Devil's Claw, turmeric, and bromelain (AINAT, 650 mg) in rheumatology centers for degenerative joint pain. In 2014, a clinically relevant improvement of chronic osteoarthritis pain was demonstrated in patients treated with 1,300 mg daily of a combination of devil's claw, curcumin, and bromelain for 60 days.

Based on a literature review, there was a dramatic decrease in the number of studies conducted on the anti-inflammatory and analgesic activity of Devil's Claw, presenting a potential research gap. Currently, in vivo clinical studies are needed to validate the prior massive in vitro studies.

Evidence strength: Preliminary to moderate for musculoskeletal pain; mostly from osteoarthritis populations and open-label or observational studies. No bursitis-specific evidence.

7.4 Bromelain

Traditional use: Bromelain is a proteolytic enzyme complex derived from pineapple (Ananas comosus). Its use in traditional Hawaiian and South American folk medicine for swelling and bruising predates modern research.

Scientific evidence: Bromelain may inhibit release of inflammatory mediators, modulate adhesion molecules, and activate fibrinolysis. Some of its pharmacologic properties may be mediated through nonprotein factors. Although most clinical trials concentrate on mitigation of arthritis pain, bromelain has been used for treatment of other inflammatory conditions. In a combination supplement pilot study, a Boswellia and bromelain-based supplement was assessed in 49 osteoarthritis patients who took the formulation for a period between 1 and 6 months.

Evidence strength: Preliminary, largely from combination-product and open-label osteoarthritis trials. No direct clinical evidence in bursitis.

8. Dietary Factors Discussed in Authoritative Sources

8.1 Diet and Gout-Related Bursitis

Gouty arthritis is a well-established cause of bursitis via urate crystal deposition in the bursa. Alterations in uric acid metabolism are associated with certain dietary patterns, particularly the consumption of food high in purine, alcohol, and fructose-sweetened beverages. These lifestyle and dietary patterns not only influence disease activity but also play a pivotal role in the initial development of gout, as they directly contribute to sustained hyperuricemia and urate crystal formation.

Consuming polyunsaturated fatty acid-rich fish, regular physical activity, and increased vegetable intake may reduce gout flares. Conversely, high purine intake (especially from animal sources), excessive alcohol consumption, and obesity are risk factors for gout exacerbation.

• Foods to limit: Beef, pork, lamb, and organ meats — including liver, kidneys, and sweetbreads — are very high in purines. Eating large amounts of these foods can raise uric acid levels and increase the risk of gout attacks. Seafood, especially anchovies, sardines, mackerel, scallops, and shellfish, is high in purines and has been linked to gout flares.
• Fructose and sugar: Drinks like soda, sweetened iced tea, energy drinks, and sugary juices are high in fructose, a type of sugar that increases uric acid production in the liver, and can also contribute to obesity, another gout risk factor.
• Alcohol: Alcoholic beverages can increase the risk of gout attacks. When the body breaks down alcohol, uric acid is produced and excretion of uric acid in the urine is slowed down.
• Vegetables: Some foods do not raise the risk of gout, including high-purine vegetables. Studies have shown that vegetables high in purines — including green peas, asparagus, and spinach — do not raise the risk of gout.
• Dairy: Studies show that drinking low-fat milk and eating low-fat dairy can reduce uric acid levels and risk of a gout attack. The proteins found in milk promote excretion of uric acid in the urine.
• Hydration: Drinking at least 8 glasses of non-alcoholic beverages a day is recommended, with plain water being best. During a flare, intake should be increased to 16 glasses a day. The water helps flush uric acid from the system.

8.2 Anti-Inflammatory Dietary Patterns

Regular physical activity and healthy eating patterns emerge as essential tools to counteract low-grade inflammation. A diet rich in bioactive compounds such as antioxidants and polyunsaturated fatty acids may regulate cytokine expression, reinforcing the role of nutrition as a therapeutic strategy.

The Dietary Inflammatory Index (DII), a validated scoring system developed from population research, provides a framework for understanding how dietary choices relate to systemic inflammation. The Dietary Inflammatory Index is associated with systemic inflammatory markers and is used to evaluate the inflammatory potential of diet. It is a standardized scoring system assessing intakes of 45 pro-inflammatory and anti-inflammatory dietary components. A higher DII score represents a pro-inflammatory diet, whereas a lower DII score represents an anti-inflammatory diet.

8.3 Obesity, Diet, and Musculoskeletal Inflammation

Obesity is a condition characterized by excessive accumulation of adipose tissue. The risk associated with obesity may be related to the function of adipose tissue via releasing pro-inflammatory cytokines. Secretion of several pro-inflammatory cytokines contributes to the development of obesity-associated comorbidities such as insulin resistance, metabolic syndrome, cardiovascular disease, and sarcopenia. These adipokine-mediated inflammatory signals can heighten the inflammatory burden in bursal and periarticular tissues.

9. Lifestyle Factors

9.1 Physical Activity

Physical activity has a complex relationship with bursitis. While overuse and repetitive mechanical loading are direct triggers for bursitis, appropriate exercise plays a role in managing the systemic inflammatory milieu that contributes to recurring bursal inflammation.

A protective association has been found between vigorous physical activity and chronic neck, low back, and hip pain. Consistently, higher sedentary time was associated with higher chronic pain prevalence. However, this protective association was attenuated by high BMI levels and high C-reactive protein. Vigorous physical activity has a protective association with chronic pain, but people with obesity and high systemic inflammation presented an attenuated beneficial association.

Physical exercise can release myokines with anti-inflammatory properties, such as interleukin-6 and irisin, which can positively modulate immune response. A systematic review of exercise interventions for people with obesity and musculoskeletal pain recommended an exercise prescription of moderate-intensity (progressing to vigorous) exercise of 30 to 60 minutes, 3 times per week, as an effective approach for managing weight and obesity-related musculoskeletal pain.

9.2 Body Weight Management

Gout is highly associated with excess weight gain and related metabolic syndromes, including obesity, diabetes, and cardiovascular disease. Weight loss statistically lowers the risk of developing gout, and it helps relieve symptoms of gout by taking stress off the joints. This relationship is particularly relevant since gouty crystal deposition is one of the direct metabolic causes of bursitis.

9.3 Smoking

Smoking, while modestly increasing risk, remains an important modifiable risk factor for bursitis. The large retrospective population study of olecranon bursitis (PubMed 2024) confirmed a statistically significant association between smoking and bursitis development.

9.4 Alcohol

Among immunocompromised patients with bursitis, the most common factors contributing to an immunocompromised state were alcoholism or steroid therapy. Alcohol further raises uric acid levels, linking its consumption to the subset of bursitis cases driven by gout.

10. Summary of Evidence Strength

• Omega-3 fatty acids (EPA/DHA): Moderate-to-strong evidence for anti-inflammatory effects and joint pain reduction in rheumatic conditions; no bursitis-specific RCTs.
• Curcumin (turmeric): Moderate evidence in osteoarthritis and rheumatoid arthritis through RCTs; bursitis-specific evidence absent; bioavailability remains a limitation.
• Boswellia serrata: Moderate evidence from meta-analysis of RCTs for osteoarthritis pain; no bursitis-specific data.
• Devil's Claw: Preliminary-to-moderate evidence for musculoskeletal pain; mainly open-label or observational studies.
• Bromelain: Preliminary evidence; primarily from combination-product and non-blinded trials.
• Vitamin C: Well-established mechanistic role in collagen and connective tissue synthesis; moderate evidence for uric acid lowering relevant to gouty bursitis; clinical trial evidence in soft tissue repair is preliminary.
• Vitamin D: Established importance in musculoskeletal health; associations with synovial inflammation are suggestive but not definitive for bursitis.
• Magnesium: Suggestive preclinical evidence for synovial joint and cartilage health; human clinical trial evidence specific to bursitis is absent.
• Dietary modification for gout: Moderately strong evidence that reducing purine-rich animal foods, alcohol, and fructose, while increasing hydration and low-fat dairy, can reduce uric acid levels and thus the frequency of gouty bursitis.

References

• Bursitis – StatPearls, NCBI Bookshelf (NIH/PubMed)
• Bursitis: Practice Essentials, Anatomy, Pathophysiology – Medscape
• Bursitis – Pathophysiology (BCcampus Open Textbook)
• Bursitis – Wikipedia
• Bursitis – Merck Manual Professional Edition
• Bursitis – ScienceDirect Topics Overview
• The immune pathology of bursitis: A systematic review – ScienceDirect / Seminars in Arthritis and Rheumatism (2024)
• Risk Factors for the Development of Olecranon Bursitis — A Large-Scale Population-Based Study – PubMed (2024)
• Risk Factors for Olecranon Bursitis – Journal of Clinical Medicine, MDPI (2024)
• Effects of omega-3 fatty acids on chronic pain: a systematic review and meta-analysis – Frontiers in Medicine (2025)
• Omega-3 fatty acids and inflammation – PubMed (2004)
• Efficacy and Safety of Curcumin and Curcuma longa Extract in Arthritis: Systematic Review and Meta-Analysis – PMC (2022)
• Effect of curcumin on rheumatoid arthritis: systematic review and meta-analysis – Frontiers in Immunology (2023)
• Curcumin Supplementation and Human Disease: A Scoping Review of Clinical Trials – PMC (2023)
• Supplement and Herb Guide for Arthritis Symptoms – Arthritis Foundation
• A Systematic Review on the Role of Vitamin C in Tissue Healing – PMC (2022)
• Efficacy of Vitamin C Supplementation on Collagen Synthesis and Oxidative Stress After Musculoskeletal Injuries: A Systematic Review – Orthopaedic Journal of Sports Medicine (2018)
• Effectiveness of Boswellia and Boswellia extract for osteoarthritis: systematic review and meta-analysis – PMC (2020)
• A complex of three natural anti-inflammatory agents provides relief of osteoarthritis pain (Devil's Claw, Turmeric, Bromelain) – PubMed (2014)
• Benefits of a Food Supplement Containing Boswellia serrata and Bromelain for Improving Quality of Life in Osteoarthritis – PubMed (2019)
• The Fight against Infection and Pain: Devil's Claw — Anti-Inflammatory Activity Review 2011–2022 – PMC (2022)
• Impact of lifestyle factors and dietary patterns on serum uric acid levels and disease activity in gout: a systematic review – PMC (2025)
• Gout and Diet: A Comprehensive Review of Mechanisms and Management – PMC (2022)
• Gout Diet Dos and Don'ts – Arthritis Foundation
• Gout diet: What's allowed, what's not – Mayo Clinic
• Magnesium in joint health and osteoarthritis – ScienceDirect / Nutrition Research (2021)
• Magnesium Supplementation Modifies Arthritis Synovial and Splenic Transcriptomic Signatures – Nutrients, MDPI (2024)
• Recognizing the musculoskeletal manifestations of vitamin D deficiency – PMC (2011)
• Obesity and Systemic Inflammation Disrupt the Compensatory Role of Physical Activity in Chronic Pain Conditions – PMC (2025)
• The Critical Role of Physical Activity and Weight Management in Knee and Hip Osteoarthritis – Journal of Rheumatology (2024)
• Association of physical activity and dietary inflammatory index with overweight/obesity in US adults: NHANES 2007–2018 – PMC (2023)